Early research (Phase 1)Ended earlyNCT04678505
What this trial is testing
Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)
Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 9